A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection

Clicks: 392
ID: 112328
2003
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Vaccination with a 9-valent pneumococcal conjugate vaccine reduced the incidence of radiologically confirmed pneumonia. The vaccine also reduced the incidence of vaccine-serotype and antibiotic-resistant invasive pneumococcal disease among children with and those without HIV infection.
Reference Key
kp2003thea Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Klugman KP;Madhi SA;Huebner RE;Kohberger R;Mbelle N;Pierce N; ;;
Journal The New England journal of medicine
Year 2003
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/14523142
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't female male Infant Clinical Trial Randomized Controlled Trial Double-Blind Method Incidence Bacterial drug resistance hiv infections / complications* pneumonia vaccines serotyping pneumococcal infections / mortality pneumococcal infections / prevention & control* pmid:14523142 doi:10.1056/nejmoa035060 keith p klugman shabir a madhi vaccine trialists group bacterial capsules haemophilus vaccines pneumococcal vaccines* / adverse effects pneumococcal / prevention & control polysaccharides streptococcus pneumoniae / classification streptococcus pneumoniae / isolation & purification conjugate / adverse effects

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.